Position in MRNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,527,594
+$3,328,543 QoQ
Shares Held
148,181
+4.1% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,138,584 across 78 Biotechnology names. MRNA ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in MRNA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,527,594 | 148,181 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,199,051 | 142,389 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,081,217 | 158,003 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,135,658 | 149,897 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $5,964,273 | 210,380 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,586,228 | 206,499 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,808,147 | 206,616 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,272,150 | 195,976 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $19,461,585 | 182,635 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $25,314,698 | 254,547 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,051,803 | 252,220 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,649,069 | 202,873 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $39,151,995 | 254,929 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $41,258,354 | 229,698 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $27,591,745 | 233,334 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $39,275,452 | 228,001 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $61,514,971 | 242,204 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $97,804,086 | 254,129 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $51,486,702 | 219,111 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $16,926,204 | 129,257 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,592,918 | 120,541 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,870,088 | 111,238 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $3,817,541 | 59,454 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||